What does Open Labels and Price Tags conclude, in numbers, about “Nocebo: the Same Formula with a Minus Sign”?
Answer: Chapter 5 recomputes the statin n-of-1 trial, with a nocebo ratio of 0.892 and only 0.055 of the symptom burden in statin months due to the drug itself, and builds a misattribution model of warning labels.
Scope of the numbers: Its parameters are illustrative; all calculations are generated by its programs; it is not medical advice, claims no effect of any product or practice on the body or on health, and its procedures and tool are non-personalised business guidance. Marked boxes separate published evidence, runnable Python calculations (21 programs), classical sources and the author's hypotheses.
Data table
The numbers below are printed verbatim by the chapter's Python program and can be reproduced by running it. standard-library Python onlyprinted values that match the answer: 0.055, 0.892
| no tablet mean | 8.0 SE from CI 1.68 |
| placebo mean 15.4 SE from CI 1.68 | |
| statin mean 16.3 SE from CI 1.68 | |
| nocebo ratio from group means: (15.4 - 8.0) / (16.3 - 8.0) | 0.892 |
| published pooled ratio 0.90; per-patient ratio 2.2 was unstable | |
| statin-month burden split: | |
| present without any tablet | 0.491 |
| added by taking a tablet | 0.454 |
| added by the statin itself | 0.055 |
| restarted within six months | 30/60 = 0.50 |
| completed all 12 months | 49/60 = 0.817 |
Show the full program
# Chapter 5. p51: The statin n-of-1 trial and the nocebo ratio.
# Published inputs: Wood et al. (2020), NEJM letter: 60 patients
# randomised, 49 completed 12 months; mean symptom score (0-100) 8.0
# (95% CI 4.7 to 11.3) in no-tablet months, 15.4 (12.1 to 18.7) on
# placebo, 16.3 (13.0 to 19.6) on atorvastatin; statin vs placebo
# P = 0.39; pooled nocebo ratio 0.90; original per-patient ratio 2.2
# (CI -62.3 to 66.7); 30 of 60 restarted statins within six months.
# The ratio of group means and the SEs from the CIs are ours.
# 他汀 n-of-1 试验:反安慰剂比的两种算法与症状负担的拆分。
from statistics import NormalDist
Z = NormalDist()
Z975 = Z.inv_cdf(0.975)
MONTHS = {"no tablet": (8.0, 4.7, 11.3), "placebo": (15.4, 12.1, 18.7),
"statin": (16.3, 13.0, 19.6)}
none, plac, stat = (MONTHS[k][0] for k in ("no tablet", "placebo",
"statin"))
for k, (m, lo, hi) in MONTHS.items():
print("{:<9} mean {:4.1f} SE from CI {:.2f}".format(
k, m, (hi - lo) / (2 * Z975)))
ratio = (plac - none) / (stat - none)
print("nocebo ratio from group means: ({:.1f} - {:.1f}) / ({:.1f} - {:.1f})"
" = {:.3f}".format(plac, none, stat, none, ratio))
print("published pooled ratio 0.90; per-patient ratio 2.2 was unstable")
print("statin-month burden split:")
print(" present without any tablet {:.3f}".format(none / stat))
print(" added by taking a tablet {:.3f}".format((plac - none) / stat))
print(" added by the statin itself {:.3f}".format((stat - plac) / stat))
print("restarted within six months: {}/{} = {:.2f}".format(30, 60, 0.5))
print("completed all 12 months: {}/{} = {:.3f}".format(49, 60, 49 / 60))Single source and citation
Fan, Y. (2026). Open-Label Placebos and Predictive Coding, Price-Tag Expectancy Gains and the Nocebo of the Bow in the Cup (Version 1.0.0), Chapter 5: Nocebo: the Same Formula with a Minus Sign. 5D Library. DOI pending
DOI pending · monograph page goes live after publication · 5DL-B-201 · v1.0.0 · CC-BY-NC-ND-4.0
BibTeX
@book{fan2026201,
author = {Fan, Yafu},
title = {Open-Label Placebos and Predictive Coding, Price-Tag Expectancy Gains and the Nocebo of the Bow in the Cup},
year = {2026},
publisher = {5D Library},
edition = {1.0.0},
note = {DOI pending}
}Other chapter answers in this book
- Chapter 1 · Telling People It Is a Sugar Pill: Three Tests of Open-Label Placebo
- Chapter 2 · Two Dollars Fifty or Ten Cents: the Expectancy Gain of a Price Tag and its Winner's Curse
- Chapter 3 · The Posterior Is a Weighted Mean: Precision-Weighted Perception and Price as a Shift of the Prior
- Chapter 4 · Where the Weight Comes From: Conditioned Learning, Rationale and the Additivity of Ritual
- Chapter 6 · The Sceptic's Three Knives: Regression to the Mean, Reporting Bias and the "Powerless Placebo"
- Chapter 7 · Classical Sources East and West: Du Xuan's Snake in the Cup and Franklin's Blindfolded Boy
- Chapter 8 · Closing the Loop: Expectation Management, Ritualised Delivery and Blinded Satisfaction Comparisons for High-Priced Experiences